Happy PharmPhriday 💊
The daughter of her town’s first Black pharmacist, in 1979, Mary Munson Runge became the first woman AND the first African American to be elected president of the American Pharmacists Association (ending 126 years straight of white male APhA presidents!)
#BlackInSTEM 🧪 🩺
The daughter of her town’s first Black pharmacist, in 1979, Mary Munson Runge became the first woman AND the first African American to be elected president of the American Pharmacists Association (ending 126 years straight of white male APhA presidents!)
#BlackInSTEM 🧪 🩺
February 2, 2024 at 1:30 PM
Happy PharmPhriday 💊
The daughter of her town’s first Black pharmacist, in 1979, Mary Munson Runge became the first woman AND the first African American to be elected president of the American Pharmacists Association (ending 126 years straight of white male APhA presidents!)
#BlackInSTEM 🧪 🩺
The daughter of her town’s first Black pharmacist, in 1979, Mary Munson Runge became the first woman AND the first African American to be elected president of the American Pharmacists Association (ending 126 years straight of white male APhA presidents!)
#BlackInSTEM 🧪 🩺
Happy #PharmPhriday! FDA approved the first-in-class non-opioid analgesic for treating moderate to severe acute pain in adults. The drug Journavx (suzetrigine) is an oral, selective inhibitor of a type of sodium ion channel called Nav1.8, expressed in sensory neurons.
#MedSky #PublicHealth 🧪
#MedSky #PublicHealth 🧪
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
www.fda.gov
January 31, 2025 at 5:58 PM
Happy #PharmPhriday! FDA approved the first-in-class non-opioid analgesic for treating moderate to severe acute pain in adults. The drug Journavx (suzetrigine) is an oral, selective inhibitor of a type of sodium ion channel called Nav1.8, expressed in sensory neurons.
#MedSky #PublicHealth 🧪
#MedSky #PublicHealth 🧪
Happy #PharmPhriday! 💊
Yesterday, a new treatment approach was added to the Parkinson’s disease toolkit in the states. The FDA approved VYALEV (foscarbidopa and foslevodopa, AbbVie), a subcutaneous, 24-hr treatment via the VYAFUSER pump.
#MedSky #Neuroskyence 🧪
1/2
Yesterday, a new treatment approach was added to the Parkinson’s disease toolkit in the states. The FDA approved VYALEV (foscarbidopa and foslevodopa, AbbVie), a subcutaneous, 24-hr treatment via the VYAFUSER pump.
#MedSky #Neuroskyence 🧪
1/2
Injectable drug to ease advanced Parkinson's disease symptoms approved by FDA
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in study participants.
www.usatoday.com
October 19, 2024 at 12:53 AM
Happy #PharmPhriday! 💊
Yesterday, a new treatment approach was added to the Parkinson’s disease toolkit in the states. The FDA approved VYALEV (foscarbidopa and foslevodopa, AbbVie), a subcutaneous, 24-hr treatment via the VYAFUSER pump.
#MedSky #Neuroskyence 🧪
1/2
Yesterday, a new treatment approach was added to the Parkinson’s disease toolkit in the states. The FDA approved VYALEV (foscarbidopa and foslevodopa, AbbVie), a subcutaneous, 24-hr treatment via the VYAFUSER pump.
#MedSky #Neuroskyence 🧪
1/2
Happy #PharmPhriday!
Last year, there were concerns about delayed gastric emptying with GLP-1 receptor agonists. This week, FDA updated labels to include a pulmonary aspiration warning during general anesthesia or deep sedation.
#MedSky 🧪 🛟
Last year, there were concerns about delayed gastric emptying with GLP-1 receptor agonists. This week, FDA updated labels to include a pulmonary aspiration warning during general anesthesia or deep sedation.
#MedSky 🧪 🛟
FDA Updates GLP-1 Label With Pulmonary Aspiration Warning
The new warning affects labels for drugs made with semaglutide, liraglutide, and tirzepatide.
www.medscape.com
November 8, 2024 at 2:24 PM
Happy #PharmPhriday!
Last year, there were concerns about delayed gastric emptying with GLP-1 receptor agonists. This week, FDA updated labels to include a pulmonary aspiration warning during general anesthesia or deep sedation.
#MedSky 🧪 🛟
Last year, there were concerns about delayed gastric emptying with GLP-1 receptor agonists. This week, FDA updated labels to include a pulmonary aspiration warning during general anesthesia or deep sedation.
#MedSky 🧪 🛟
For #PharmPhriday, we have an FDA warning letter.
A study participant received ~100x the dose of an investigational product via IV infusion, was hospitalized, experienced multiple serious adverse events including cardiac arrest, and ultimately died.
www.fda.gov/inspections-... #PharmSky 🧪 🛟
A study participant received ~100x the dose of an investigational product via IV infusion, was hospitalized, experienced multiple serious adverse events including cardiac arrest, and ultimately died.
www.fda.gov/inspections-... #PharmSky 🧪 🛟
Devalingam Mahalingam, M.D., Ph.D. - 721145 - 12/11/2025
Clinical Investigator
www.fda.gov
January 16, 2026 at 2:01 PM
For #PharmPhriday, we have an FDA warning letter.
A study participant received ~100x the dose of an investigational product via IV infusion, was hospitalized, experienced multiple serious adverse events including cardiac arrest, and ultimately died.
www.fda.gov/inspections-... #PharmSky 🧪 🛟
A study participant received ~100x the dose of an investigational product via IV infusion, was hospitalized, experienced multiple serious adverse events including cardiac arrest, and ultimately died.
www.fda.gov/inspections-... #PharmSky 🧪 🛟
Happy PharmPhriday 💊
What is a drug name that you would name yourself (or a pet or child)?
I think I’d go with Lunesta (eszopiclone), a positive allosteric modulator of the GABA-A receptor, used for insomnia 💤
🧪 🩺 #neuroskyence
What is a drug name that you would name yourself (or a pet or child)?
I think I’d go with Lunesta (eszopiclone), a positive allosteric modulator of the GABA-A receptor, used for insomnia 💤
🧪 🩺 #neuroskyence
August 25, 2023 at 10:53 AM
Happy PharmPhriday 💊
What is a drug name that you would name yourself (or a pet or child)?
I think I’d go with Lunesta (eszopiclone), a positive allosteric modulator of the GABA-A receptor, used for insomnia 💤
🧪 🩺 #neuroskyence
What is a drug name that you would name yourself (or a pet or child)?
I think I’d go with Lunesta (eszopiclone), a positive allosteric modulator of the GABA-A receptor, used for insomnia 💤
🧪 🩺 #neuroskyence
Generic drugs do not contain 80-125% of the active pharmaceutical ingredient (API) of the brand name drug.
The 90% confidence interval of the PK ratio between the test and reference product should be between 0.8 and 1.25
🩺 🧪 PharmPhriday 💊
The 90% confidence interval of the PK ratio between the test and reference product should be between 0.8 and 1.25
🩺 🧪 PharmPhriday 💊
September 22, 2023 at 10:14 PM
Generic drugs do not contain 80-125% of the active pharmaceutical ingredient (API) of the brand name drug.
The 90% confidence interval of the PK ratio between the test and reference product should be between 0.8 and 1.25
🩺 🧪 PharmPhriday 💊
The 90% confidence interval of the PK ratio between the test and reference product should be between 0.8 and 1.25
🩺 🧪 PharmPhriday 💊
Happy PharmPhriday 💊
Yesterday, the FDA approved the first nonsteroidal drug (‘Duvyzat’, givinostat) to treat Duchenne Muscular Dystrophy (DMD), in people 6+. DMD is a rare, neurological disorder which causes muscle deterioration, leading to breathing problems and early death.
Tags: 🩺 🧪 🧠🦋 🛟
Yesterday, the FDA approved the first nonsteroidal drug (‘Duvyzat’, givinostat) to treat Duchenne Muscular Dystrophy (DMD), in people 6+. DMD is a rare, neurological disorder which causes muscle deterioration, leading to breathing problems and early death.
Tags: 🩺 🧪 🧠🦋 🛟
FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy
The FDA approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients six years of age and older.
www.fda.gov
March 22, 2024 at 6:50 PM
Happy PharmPhriday 💊
Yesterday, the FDA approved the first nonsteroidal drug (‘Duvyzat’, givinostat) to treat Duchenne Muscular Dystrophy (DMD), in people 6+. DMD is a rare, neurological disorder which causes muscle deterioration, leading to breathing problems and early death.
Tags: 🩺 🧪 🧠🦋 🛟
Yesterday, the FDA approved the first nonsteroidal drug (‘Duvyzat’, givinostat) to treat Duchenne Muscular Dystrophy (DMD), in people 6+. DMD is a rare, neurological disorder which causes muscle deterioration, leading to breathing problems and early death.
Tags: 🩺 🧪 🧠🦋 🛟
It’s PharmPhriday 💊 🩺 🧪 🛟
Early 1700s: An enslaved man (given name Onesimus) explained to Cotton Mather (his owner) how he was inoculated against smallpox. After verifying and learning more, Mather tried to spread the word through Mass (wildly unpopular). The procedure was tested in 1721 and worked!
Early 1700s: An enslaved man (given name Onesimus) explained to Cotton Mather (his owner) how he was inoculated against smallpox. After verifying and learning more, Mather tried to spread the word through Mass (wildly unpopular). The procedure was tested in 1721 and worked!
How an Enslaved African Man in Boston Helped Save Generations from Smallpox | HISTORY
In the early 1700s, Onesimus shared a revolutionary way to prevent smallpox.
www.history.com
February 23, 2024 at 3:57 PM
It’s PharmPhriday 💊 🩺 🧪 🛟
Early 1700s: An enslaved man (given name Onesimus) explained to Cotton Mather (his owner) how he was inoculated against smallpox. After verifying and learning more, Mather tried to spread the word through Mass (wildly unpopular). The procedure was tested in 1721 and worked!
Early 1700s: An enslaved man (given name Onesimus) explained to Cotton Mather (his owner) how he was inoculated against smallpox. After verifying and learning more, Mather tried to spread the word through Mass (wildly unpopular). The procedure was tested in 1721 and worked!
Oops, I never hit send on this #PharmPhriday
The FDA is notifying application holders for drugs containing carbidopa/levodopa (used for Parkinson’s) that FDA is requiring an additional warning to state the meds can cause B6 deficiency and B6 deficiency-associated seizures.
#PharmSky #MedSky 🧪 🧠🟦
The FDA is notifying application holders for drugs containing carbidopa/levodopa (used for Parkinson’s) that FDA is requiring an additional warning to state the meds can cause B6 deficiency and B6 deficiency-associated seizures.
#PharmSky #MedSky 🧪 🧠🟦
FDA Drug Safety Communication: Drug Products Containing Carbidopa/Levo
FDA Drug Safety Communication
www.fda.gov
March 23, 2026 at 3:56 PM
Oops, I never hit send on this #PharmPhriday
The FDA is notifying application holders for drugs containing carbidopa/levodopa (used for Parkinson’s) that FDA is requiring an additional warning to state the meds can cause B6 deficiency and B6 deficiency-associated seizures.
#PharmSky #MedSky 🧪 🧠🟦
The FDA is notifying application holders for drugs containing carbidopa/levodopa (used for Parkinson’s) that FDA is requiring an additional warning to state the meds can cause B6 deficiency and B6 deficiency-associated seizures.
#PharmSky #MedSky 🧪 🧠🟦
I missed this for #PharmPhriday, so it’s now a #MedicineMonday!
The FDA just approved the first drug for obstructive sleep apnea. You may have already heard of Zepbound (tirzepatide). It can now be used for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. More 👇🏽
The FDA just approved the first drug for obstructive sleep apnea. You may have already heard of Zepbound (tirzepatide). It can now be used for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. More 👇🏽
FDA Approves First Medication for Obstructive Sleep Apnea
Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
www.fda.gov
December 23, 2024 at 3:41 PM
I missed this for #PharmPhriday, so it’s now a #MedicineMonday!
The FDA just approved the first drug for obstructive sleep apnea. You may have already heard of Zepbound (tirzepatide). It can now be used for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. More 👇🏽
The FDA just approved the first drug for obstructive sleep apnea. You may have already heard of Zepbound (tirzepatide). It can now be used for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. More 👇🏽
Happy PharmPhriday 💊 🧪 🩺 #BlackInSTEM
Julia Pearl Hughes was pharmacist, entrepreneur, and activist, the first Black woman to run for elected office in NY and believed to be the first Black woman pharmacist to own and operate her own drug store. Far too much for one post! Learn more here:
Julia Pearl Hughes was pharmacist, entrepreneur, and activist, the first Black woman to run for elected office in NY and believed to be the first Black woman pharmacist to own and operate her own drug store. Far too much for one post! Learn more here:
Julia Pearl Hughes (1873-1950) •
Julia Pearl Hughes (Coleman-Robinson) was the first African American woman to successfully own and operate her own drugstore. Hughes was born to John and Mary Hughes in Melville Township, Alamance Cou...
www.blackpast.org
February 16, 2024 at 1:24 PM
Happy PharmPhriday 💊 🧪 🩺 #BlackInSTEM
Julia Pearl Hughes was pharmacist, entrepreneur, and activist, the first Black woman to run for elected office in NY and believed to be the first Black woman pharmacist to own and operate her own drug store. Far too much for one post! Learn more here:
Julia Pearl Hughes was pharmacist, entrepreneur, and activist, the first Black woman to run for elected office in NY and believed to be the first Black woman pharmacist to own and operate her own drug store. Far too much for one post! Learn more here:
Happy PharmPhriday 💊
I love this vintage ad. Toothache? How about some cocaine tooth drops!
Topical cocaine provides a local anesthetic effect by blocking sodium channels and interfering with action potentials. No action potential, no pain signal.
🩺 🧪 🗃️ #HistSci
I love this vintage ad. Toothache? How about some cocaine tooth drops!
Topical cocaine provides a local anesthetic effect by blocking sodium channels and interfering with action potentials. No action potential, no pain signal.
🩺 🧪 🗃️ #HistSci
January 5, 2024 at 12:40 PM
Happy PharmPhriday 💊
I love this vintage ad. Toothache? How about some cocaine tooth drops!
Topical cocaine provides a local anesthetic effect by blocking sodium channels and interfering with action potentials. No action potential, no pain signal.
🩺 🧪 🗃️ #HistSci
I love this vintage ad. Toothache? How about some cocaine tooth drops!
Topical cocaine provides a local anesthetic effect by blocking sodium channels and interfering with action potentials. No action potential, no pain signal.
🩺 🧪 🗃️ #HistSci
Happy #PharmPhriday!
FDA just approved the first treatment for Niemann-Pick Disease, Type C, a rare genetic disorder resulting in neurological symptoms and organ dysfunction, due to changes in the NPC1 or NPC2 genes impacting transport of lipids in a cell. Life expectancy is about 13.
🧪 🩺 🟦🧠 🛟
FDA just approved the first treatment for Niemann-Pick Disease, Type C, a rare genetic disorder resulting in neurological symptoms and organ dysfunction, due to changes in the NPC1 or NPC2 genes impacting transport of lipids in a cell. Life expectancy is about 13.
🧪 🩺 🟦🧠 🛟
FDA Approves First Treatment for Niemann-Pick Disease, Type C
The FDA approved Miplyffa (arimoclomol), an oral medication for the treatment of Neimann-Pick disease, type C (NPC).
www.fda.gov
September 20, 2024 at 2:41 PM
Happy #PharmPhriday!
FDA just approved the first treatment for Niemann-Pick Disease, Type C, a rare genetic disorder resulting in neurological symptoms and organ dysfunction, due to changes in the NPC1 or NPC2 genes impacting transport of lipids in a cell. Life expectancy is about 13.
🧪 🩺 🟦🧠 🛟
FDA just approved the first treatment for Niemann-Pick Disease, Type C, a rare genetic disorder resulting in neurological symptoms and organ dysfunction, due to changes in the NPC1 or NPC2 genes impacting transport of lipids in a cell. Life expectancy is about 13.
🧪 🩺 🟦🧠 🛟
Happy PharmPhriday 💊
Vintage drug ads are one of my favorite things and among the top thoughts when someone says they long for “the good old days” (oh yeah? Was it the blatant racism, sexism, and bigotry, and the heavy sedative use?)
What are some of your favorite vintage drug ads or labels? 🧪 🩺
Vintage drug ads are one of my favorite things and among the top thoughts when someone says they long for “the good old days” (oh yeah? Was it the blatant racism, sexism, and bigotry, and the heavy sedative use?)
What are some of your favorite vintage drug ads or labels? 🧪 🩺
August 11, 2023 at 10:50 AM
Happy PharmPhriday 💊
Vintage drug ads are one of my favorite things and among the top thoughts when someone says they long for “the good old days” (oh yeah? Was it the blatant racism, sexism, and bigotry, and the heavy sedative use?)
What are some of your favorite vintage drug ads or labels? 🧪 🩺
Vintage drug ads are one of my favorite things and among the top thoughts when someone says they long for “the good old days” (oh yeah? Was it the blatant racism, sexism, and bigotry, and the heavy sedative use?)
What are some of your favorite vintage drug ads or labels? 🧪 🩺
Happy PharmPhriday 💊
Got a cough? You might be prescribed benzonatate (Tessalon) pearls which work on vagal afferent fibers and stretch receptors to ⬇️ the cough reflex.
Be aware: Accidental ingestion by kids <10 can cause overdose and death. Symptoms can be rapid, within 15-20min of ingestion 🩺 🧪
Got a cough? You might be prescribed benzonatate (Tessalon) pearls which work on vagal afferent fibers and stretch receptors to ⬇️ the cough reflex.
Be aware: Accidental ingestion by kids <10 can cause overdose and death. Symptoms can be rapid, within 15-20min of ingestion 🩺 🧪
Death resulting from overdose after accidental ingestion of Tessalon
FDA Drug Safety Communication: Death resulting from overdose after accidental ingestion of Tessalon (benzonatate) by children under 10 years of age
www.fda.gov
August 18, 2023 at 3:57 PM
Happy PharmPhriday 💊
Got a cough? You might be prescribed benzonatate (Tessalon) pearls which work on vagal afferent fibers and stretch receptors to ⬇️ the cough reflex.
Be aware: Accidental ingestion by kids <10 can cause overdose and death. Symptoms can be rapid, within 15-20min of ingestion 🩺 🧪
Got a cough? You might be prescribed benzonatate (Tessalon) pearls which work on vagal afferent fibers and stretch receptors to ⬇️ the cough reflex.
Be aware: Accidental ingestion by kids <10 can cause overdose and death. Symptoms can be rapid, within 15-20min of ingestion 🩺 🧪
Happy PharmPhriday 💊 🩺
Anna Louise James was one of the first Black women to become a licensed pharmacist in the US and first in Connecticut. She worked in her BIL’s pharmacy till he left for WWI in 1917 and ran the pharmacy for 50 years. She passed in 1977 at the age of 91.
#BlackInSTEM
Anna Louise James was one of the first Black women to become a licensed pharmacist in the US and first in Connecticut. She worked in her BIL’s pharmacy till he left for WWI in 1917 and ran the pharmacy for 50 years. She passed in 1977 at the age of 91.
#BlackInSTEM
Herstory: How a Barrier-Breaking Pharmacist's Legacy Lives on in Old Saybrook
Anna Louise James made history in Connecticut in the early 1900s when she became the first female African American pharmacist in Connecticut. Miss James, as she was known, owned James Pharmacy in Old Saybrook, where she served the community for decades. “She was the person in town who people went to for their medicines, and just to talk and to…
www.nbcconnecticut.com
February 9, 2024 at 12:33 PM
Happy PharmPhriday 💊 🩺
Anna Louise James was one of the first Black women to become a licensed pharmacist in the US and first in Connecticut. She worked in her BIL’s pharmacy till he left for WWI in 1917 and ran the pharmacy for 50 years. She passed in 1977 at the age of 91.
#BlackInSTEM
Anna Louise James was one of the first Black women to become a licensed pharmacist in the US and first in Connecticut. She worked in her BIL’s pharmacy till he left for WWI in 1917 and ran the pharmacy for 50 years. She passed in 1977 at the age of 91.
#BlackInSTEM